title: [Iron-chelating treatment].
authors.forename: C
authors.initials: C
authors.lastname: Vullo
authors.forename: A
authors.initials: A
authors.lastname: Di Palma
authors.forename: V
authors.initials: V
authors.lastname: De Sanctis
authors.forename: L
authors.initials: L
authors.lastname: Borgatti
authors.forename: G
authors.initials: G
authors.lastname: Atti
mesh_terms: D015913:Chelation Therapy; D000077543:Deferiprone; D003676:Deferoxamine / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004920:Erythropoiesis; D006486:Hemosiderosis / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007501:Iron; D007502:Iron Chelating Agents / Q000627:therapeutic use*; D004369:Pentetic Acid / Q000627:therapeutic use; D011728:Pyridones / Q000627:therapeutic use; D013789:Thalassemia / Q000150:complications* / Q000378:metabolism
chemical_list: D007502:Iron Chelating Agents; D011728:Pyridones; D000077543:Deferiprone; D004369:Pentetic Acid; D007501:Iron; D003676:Deferoxamine
vernacular_title: Trattamento ferrochelante.